Jacobi Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Jacobi Capital Management’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-975	Closed	-$44K	–	1240
2020 Q1	$44K	Buy	+975	New	+$49.2K	0.01%	439
2018 Q3	–	Sell	-330	Closed	-$17K	–	1017
2018 Q2	$17K	Hold	330	–	–	﹤0.01%	613
2018 Q1	$16K	Hold	330	–	–	﹤0.01%	607
2017 Q4	$17K	Hold	330	–	–	0.01%	571
2017 Q3	$17K	Hold	330	–	–	0.01%	542
2017 Q2	$17K	Buy	+330	New	+$16.7K	0.01%	479

Other funds holding IHE

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Jacobi Capital Management's IHE Position: Q2 2020 in Review

Jacobi Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2020, closing a stake of 975 shares — an estimated $44K sold.

Jacobi Capital Management first reported a position in IHE in Q2 2017 and held it in 6 quarters. The position peaked at $44K in Q1 2020. 91 funds tracked by Wall St. Rank hold IHE as of Q2 2020.

Jacobi Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
Jacobi Capital Management sold 975 iShares US Pharmaceuticals ETF shares in Q2 2020, an estimated $44K.
Jacobi Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2017 and held it in 6 quarters.
Jacobi Capital Management's iShares US Pharmaceuticals ETF position peaked at $44K in Q1 2020.
91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2020.

Based on Jacobi Capital Management's 13F filing for Q2 2020, filed 27 Jul 2020.